Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine.
Metformin-induced thyrotropin suppression is not associated with cardiac effects
CAPPELLI, Carlo;PIROLA, Ilenia;AGOSTI, BARBARA;SALVETTI, Massimo;CASTELLANO, Maurizio
2014-01-01
Abstract
Metformin treatment may induce a decrease/suppression in serum TSH levels, mimicking sub-clinical hyperthyroidism (SHT). The aim of the present study was to retrospectively evaluate changes in several electrocardiographic indices in euthyroid subjects with diabetes who, after starting metformin treatment, developed a low serum TSH as compared to patients with SHT resulting from an underlying thyroid disease or TSH suppressive treatment with L-thyroxine.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2014_Metformin.pdf
accesso aperto
Tipologia:
Full Text
Licenza:
PUBBLICO - Pubblico senza Copyright
Dimensione
435.01 kB
Formato
Adobe PDF
|
435.01 kB | Adobe PDF | Visualizza/Apri |
|
2014_Metformin.pdf
accesso aperto
Tipologia:
Full Text
Licenza:
PUBBLICO - Pubblico senza Copyright
Dimensione
435.01 kB
Formato
Adobe PDF
|
435.01 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
